Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Capital Expenditures (2018 - 2026)

Health Catalyst filings provide 9 years of Capital Expenditures readings, the most recent being $38000.0 for Q1 2026.

  • On a quarterly basis, Capital Expenditures fell 79.79% to $38000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$74000.0, a 957.14% decrease, with the full-year FY2025 number at $76000.0, up 484.62% from a year prior.
  • Capital Expenditures hit $38000.0 in Q1 2026 for Health Catalyst, down from $73000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $2.0 million in Q4 2022 to a low of -$1.2 million in Q4 2024.
  • Median Capital Expenditures over the past 5 years was $74000.0 (2023), compared with a mean of $143812.5.
  • Biggest five-year swings in Capital Expenditures: tumbled 255.17% in 2024 and later skyrocketed 344.66% in 2025.
  • Health Catalyst's Capital Expenditures stood at $2.0 million in 2022, then plummeted by 147.82% to -$974000.0 in 2023, then fell by 22.18% to -$1.2 million in 2024, then skyrocketed by 106.13% to $73000.0 in 2025, then plummeted by 47.95% to $38000.0 in 2026.
  • The last three reported values for Capital Expenditures were $38000.0 (Q1 2026), $73000.0 (Q4 2025), and -$437000.0 (Q3 2025) per Business Quant data.